R&D/ Views & Analysis/ Views and analysis Can psychedelics provide breakthrough in mental health? Ben Hargreaves DMT, LSD, psilocybin, psychedelics, WHO 0 Comment There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they Share X Can psychedelics provide breakthrough in mental health? https://pharmaphorum.com/r-d/can-psychedelics-provide-breakthrough-in-mental-health/
News/ News/ R&D Small Pharma stock market launch funds DMT-based depression drug trial Richard Staines depression, DMT, psychedelic drugs, R&D 0 Comment UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 58 million Canadian dollars (around £34m) Share X Small Pharma stock market launch funds DMT-based depression drug trial https://pharmaphorum.com/news/small-pharma-launches-on/
